Wall Street ... in GSK surged nearly 2% in early trading in London after the pharmaceutical giant announced it would invest £50m in a groundbreaking project with the University of Oxford.

GSK has selected a site currently being constructed on the corner of New Oxford Street and Earnshaw Street – known as the Earnshaw building – for its new HQ, which is currently located to the ...

The budget carrier blamed the decrease on delays in deliveries of new planes from ... Drugmaker GSK (GSK.L) rose more than 1.5% in early trade on Monday, buoyed by news that it has struck a £50m deal ...

THE boss of an electric car-charging firm that last week received £55million from taxpayers has admitted it broke the law by ...

DRUG giant GSK and the University of Oxford have formed a tie-up to create a new cancer vaccine ... a swoop on WH Smith’s unwanted 500 high street stores, The Sun can reveal.

Trade is not a one-way street, and economists have forecast US growth slowing ... This reflects the fact that AstraZeneca (AZN), GSK (GSK) and Smith & Nephew (SN.) all have significant in-country ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / Rosen Law Firm PAWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers ...

NEW YORK, NY / ACCESS Newswire / February 14, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...

Professor Sarah Blagden, from the University of Oxford, will co-lead the new GSK-Oxford Cancer Immuno-Prevention Programme, which is backed by £50 million from GSK. She told BBC Radio 4’s Today ...

and GSK has to prove its drug development pipeline is packed with new blockbuster treatments. “An increased dividend and the launch of a first major share buyback in more than a decade suggest ...